新型血管内穿孔蛛网膜下腔出血模型用于研究迟发性脑损伤机制
研究在轻度血管内穿孔蛛网膜下腔出血大鼠模型基础上,于诱导后24小时行单侧颈总动脉闭塞以模拟早期脑低灌注,建立用于研究迟发性脑损伤的新模型;该模型死亡率低,且早期脑损伤、反应性星形胶质细胞增生、脑血管痉挛及迟发性脑损伤均显著加重。
要点
- 轻度SAH模型24小时内死亡率为5.4%。
- SAH+UCCAO组至第7天无大鼠死亡。
- SAH+UCCAO组早期脑损伤、反应性星形胶质细胞增生、脑血管痉挛及迟发性脑损伤均显著加重。
核心结论
- SAH+UCCAO模型可模拟早期脑损伤伴反应性星形胶质细胞增生、脑血管痉挛及迟发性脑损伤加重,且不伴高死亡率。
研究设计与样本
- 共109只成年雄性Sprague-Dawley大鼠随机分为无SAH组和SAH组,无SAH组于第1天随机分为假手术组和UCCAO组,神经功能评分≥15分的SAH大鼠随机分为SAH-UCCAO组和SAH+UCCAO组。
主要发现
- 轻度SAH模型24小时内死亡率为5.4%。
- SAH+UCCAO组至第7天无大鼠死亡。
- SAH+UCCAO组早期脑损伤、反应性星形胶质细胞增生、脑血管痉挛及迟发性脑损伤均显著加重。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Delayed brain injury (DBI) is considered one of the most important causes of mortality and morbidity after subarachnoid hemorrhage (SAH). However, no suitable experimental rat endovascular perforation (EVP) SAH model was available for investigating DBI. The authors added early cerebral hypoperfusion to a mild EVP SAH model by unilateral common carotid artery occlusion (UCCAO) 24 hours after induction of SAH to mimic the clinical course of early cerebral hypoperfusion after SAH. METHODS: A total of 109 adult male Sprague-Dawley rats were randomly divided into 2 groups: no SAH and SAH. Next, no-SAH rats were randomly divided on day 1 into 2 groups: sham and UCCAO. SAH rats with a neurological score of 15 or greater were randomly divided into 2 groups: SAH - UCCAO and SAH + UCCAO group. RESULTS: The mild SAH model had a lower mortality rate of 5.4% within the first 24 hours. No rat died in the SAH + UCCAO group until day 7. DBI as well as early brain injury (EBI), reactive astrogliosis, and cerebral vasospasm significantly worsened in the SAH + UCCAO group. CONCLUSIONS: The present SAH + UCCAO model can simulate EBI with aggravation of reactive astrogliosis, cerebral vasospasm, and DBI but without high mortality.
引用
- Kumagai K, Tomiyama A, Takeuchi S, et al. New endovascular perforation subarachnoid hemorrhage model for investigating the mechanisms of delayed brain injury. J Neurosurg. 2019. PMID: 31756704. doi:10.3171/2019.9.JNS191934
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。